0001842952-24-000037.txt : 20240516 0001842952-24-000037.hdr.sgml : 20240516 20240516160126 ACCESSION NUMBER: 0001842952-24-000037 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240516 DATE AS OF CHANGE: 20240516 EFFECTIVENESS DATE: 20240516 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Context Therapeutics Inc. CENTRAL INDEX KEY: 0001842952 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 863738787 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-513547 FILM NUMBER: 24955372 BUSINESS ADDRESS: STREET 1: 2001 MARKET STREET STREET 2: SUITE 3915 UNIT #15 CITY: PHILADELPHIA STATE: PA ZIP: 19103 BUSINESS PHONE: 267-225-7416 MAIL ADDRESS: STREET 1: 2001 MARKET STREET STREET 2: SUITE 3915 UNIT #15 CITY: PHILADELPHIA STATE: PA ZIP: 19103 FORMER COMPANY: FORMER CONFORMED NAME: Context Therapeutics LLC DATE OF NAME CHANGE: 20210128 D 1 primary_doc.xml X0708 D LIVE 0001842952 Context Therapeutics Inc. 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA PENNSYLVANIA 19103 267-225-7416 DELAWARE Context Therapeutics LLC Corporation true 2021 Martin Albert Lehr 2001 Market Street Suite 3915, Unit #15 Philadelphia PA PENNSYLVANIA 19103 Executive Officer Director Jennifer Minai-Azary 2001 Market Street Suite 3915, Unit #15 Philadelphia PA PENNSYLVANIA 19103 Executive Officer Alex Levit 2001 Market Street Suite 3915, Unit #15 Philadelphia PA PENNSYLVANIA 19103 Executive Officer Linda Beth West 2001 Market Street Suite 3915, Unit #15 Philadelphia PA PENNSYLVANIA 19103 Director Jennifer Evans Stacey 2001 Market Street Suite 3915, Unit #15 Philadelphia PA PENNSYLVANIA 19103 Director Richard Jay Berman 2001 Market Street Suite 3915, Unit #15 Philadelphi PA PENNSYLVANIA 19103 Director Philip Kantoff 2001 Market Street Suite 3915, Unit #15 Philadelphia PA PENNSYLVANIA 19103 Director Pharmaceuticals No Revenues 06b false 2024-05-06 false true true false 0 Piper Sandler & Co. 665 None None 800 Nicollet Mall Minneapolis MN MINNESOTA 55402 CA CALIFORNIA CT CONNECTICUT GA GEORGIA IL ILLINOIS NJ NEW JERSEY NY NEW YORK NC NORTH CAROLINA PA PENNSYLVANIA TX TEXAS false 99998250 99992767 5483 Includes sale of (i) 59,032,259 shares of common stock ("Common Stock") at $1.55 per share &(ii) pre-funded warrants to purchase 5,482,741 shares of Common Stock, at exercise price of $0.001 per share, with $1.549 per share paid by each warrant purchaser. false 26 4999638 0 0 false Context Therapeutics Inc. /s/ Martin Lehr Martin Lehr Chief Executive Officer 2024-05-16